- Data in Taiwan Shows That Antiretroviral Therapies Have Helped Transform HIV Into a Chronic Condition and Bring Positive Change in the Outlook for People Living with HIV - SINGAPORE, June 16, 2022 /PRNewswire/ Gilead Sciences, Inc. today announced results from an online survey that assessed the health-related quality of life (HRQOL) among people living with HIV (PLWH) in Taiwan who are virally suppressed as compared to the general population. The data shows that those who are virally suppressed experience similar HRQOL as the general population and highlights the importance of evaluating an individual's quality of life, including both physical and mental health-related issues, beyond viral suppression. The findings will be presented at the virtual Asia-Pacific AIDS and Co-Infections Conference (APACC) 2022, taking place 16 June to 18 June. "For many years, PLWH have been challenged by fear of the future and uncertainty about their life expectancy. This has been compounded b